Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Meridian Small Cap Growth Fund's investment thesis on Tandem Diabetes Care ($TNDM) — Q1 2025 | Buyside Digest

All Pitches

View Letter Analysis

$TNDMNASDAQTandem Diabetes Care

BULL

Meridian Small Cap Growth Fund—TNDM

Fund Letter

Q1 2025

Published March 31, 2025

View Fund Profile

$16.31USD

-18.0% vs last month

$16.88Pitched

-3.4% since pitch

Market Cap$1.3B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Tandem Diabetes Care is an automated insulin delivery technology provider poised for long-term growth in both Type 1 and Type 2 diabetes markets. Although near-term U.S....

— Chad Meade

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $TNDM, and what else Meridian Small Cap Growth Fund is buying.

Other pitches on $TNDM

Other investors who've written on Tandem Diabetes Care

No other institutional pitches found for this ticker yet.

View all $TNDM pitches →